Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area epigenetics hypoxia inducible factors'

Search results for: 'research area epigenetics hypoxia inducible factors'

Items 101-110 of 114

Page
per page
  1. Ki16198
    B1591 Ki16198
    Target: LPA Receptors
    Summary: LPA antagonist
  2. Nifuroxazide
    B1799 Nifuroxazide
    Target: STAT
    Summary: STAT inhibitor
      ≥27.5 mg/mL
  3. CUDC-101
    A4092 CUDC-101
     1 Citation
    Target: Histone Deacetylases (HDACs)|EGFR|ErbB
    Summary: Multitargeted HDAC inhibitor
      ≥21.7 mg/mL
  4. XMD8-92
    A3943 XMD8-92
    Target: ERK
    Summary: BMK1/ERK5 inhibitor
      ≥23.75 mg/mL
  5. Tanshinone IIA
    N1846 Tanshinone IIA
    Target: AP-1|MAGL
    Summary: Antioxidant and anti-inflammatory reagent
      insoluble in EtOH; insoluble in H2O; ≥3.42 mg/mL
  6. Dovitinib (TKI258) Lactate
    B5953 Dovitinib (TKI258) Lactate
    Target: CSF-1R|FLT3|VEGFR|PDGFR|c-Kit|FGFR
    Summary: Oral tyrosine kinase inhibitor (TKI) against FGFR1–3, VEGFR1–3, and platelet-derived growth factor receptor (PDGFR).
      insoluble in EtOH; ≥10.62 mg/mL
  7. Cucurbitacin I
    A4512 Cucurbitacin I
    Target: STAT|JAK
    Summary: STAT3/JAK2 signaling inhibitor
      ≥22.45 mg/mL
  8. AT13387
    A4056 AT13387
    Target: HSP90
    Summary: Hsp90 inhibitor
      insoluble in H2O; ≥13.25 mg/mL
  9. Gefitinib (ZD1839)
    A8219 Gefitinib (ZD1839)
     3 Citation
    Target: EGFR
    Summary: Selective EGFR inhibitor
      ≥22.34 mg/mL
  10. Vatalanib (PTK787) 2HCl
    A1778 Vatalanib (PTK787) 2HCl
    Target: VEGFR
    Summary: Tyrosine kinase receptor inhibitor
      ≥21 mg/mL

Items 101-110 of 114

Page
per page
Shop By
Now Shopping by
  1. Related Disease Cancer Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 113item
  2. Natural Products 1 item
Specificity
  1. Selective 87item
Reversibility
  1. Reversible 2item
  2. Irreversible 4item
Target
  1. Caspases 2item
  2. Histone Deacetylases (HDACs) 15item
  3. Bcl-2 1 item
  4. PI3K 1 item
  5. Raf 2item
  6. Aurora Kinases 13item
  7. Bcl-xl 1 item
  8. CSF-1R 3item
  9. EZH2 2item
  10. Bromodomains 2item
  11. AP-1 1 item
  12. DT-diaphorases 1 item
  13. FLT3 4item
  14. LPA Receptors 1 item
  15. PLK 2item
  16. VEGFR 12item
  17. PDGFR 8item
  18. c-Kit 4item
  19. RET 1 item
  20. Bromodomain-containing proteins(BRDs) 1 item
  21. Mcl-1 1 item
  22. SGK 1 item
  23. DOT1L 1 item
  24. FGFR 7item
  25. Insulin-like growth factor receptors(IGFRs) 1 item
  26. Pim 2item
  27. Liver X receptors (LXRs) 1 item
  28. Sir2-like Family Deacetylases (Sirtuins) 1 item
  29. Deubiquitinating enzymes (DUBs) 1 item
  30. PP1 1 item
  31. PP2A 1 item
  32. Smoothened 1 item
  33. MET 1 item
  34. Src 1 item
  35. Trk Receptors 1 item
  36. STAT 3item
  37. EGFR 7item
  38. Hypoxia Inducible Factors (HIFs) 1 item
  39. JAK 5item
  40. DNA-PK 1 item
  41. HSP90 1 item
  42. Topoisomerases 1 item
  43. ErbB 3item
  44. Actin 1 item
  45. DNA Methyltransferases 3item
  46. ERK 1 item
  47. PKC 1 item
  48. CREBBP 1 item
  49. EP300 1 item
  50. Lyn 1 item
  51. HER2 1 item
  52. Insulin and Insulin-like Receptors 1 item
  53. PARP 1 item
  54. ALK 1 item
  55. Dehydrogenase 1 item
  56. Autophagy 2item
  57. Farnesyl Diphosphate Synthases 1 item
  58. MAGL 1 item
  59. Apoptosis Inducers 1 item
  60. O6-methylguanine-DNA-methyl-transferase (MGMT) 1 item
  61. Cytidine deaminases 1 item
  62. PP4 1 item
  63. VEGFR3/FLT4 1 item
  64. NTRK1/TRKA 1 item
  65. CSF-1R/c-Fms 1 item
  66. p53 2item
  67. HDAC 1 item
  68. insulin 1 item
  69. HDM2 ubiquitin ligase 1 item
  70. GLI 1 item
  71. Trx 1 item
  72. TYK2 1 item
  73. MUSK 1 item
  74. MAP3K 1 item
  75. RHA 1 item
Reported Experiments
  1. Animal Experiments 104item
  2. Cell Experiments 69item